Benign Vaginal Mixed Epithelial And Mesenchymal Neoplasm C1511106
A rare, non-cancerous tumor of the vagina containing both epithelial and mesenchymal tissue. Typically affects adult women and is treated with surgical removal, with generally excellent outcomes.
Key facts at a glance
- ICD-10
- N50.9
- ICD-11
- GA00.0
- Body system
- reproductive
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(reproductive)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Vaginal bleeding
(reproductive)Vaginal discharge
(reproductive)Pelvic pain
(reproductive)Urinary urgency
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Colposcopic surveillance
Regular vaginal examination with colposcopy and biopsy as indicated to monitor the mixed epithelial and mesenchymal neoplasm for any concerning changes.
Wide local excision
Complete surgical removal of the vaginal neoplasm with adequate margins to ensure complete excision while preserving vaginal function and structure.
Additional treatment options
Laser vaporization
Precise laser energy application to destroy abnormal vaginal tissue with minimal damage to surrounding structures, suitable for smaller lesions.
procedureCryotherapy treatment
Freezing technique using extreme cold to destroy vaginal neoplasm cells, often used for accessible surface lesions.
procedureTopical immunotherapy
Application of topical immunomodulatory agents such as imiquimod to stimulate local immune response against the vaginal neoplasm.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Benign Vaginal Mixed Epithelial And Mesenchymal Neoplasm C1511106?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
McClure KM, Patterson LK, Chen WH. Mixed epithelial and mesenchymal tumors of the female genital tract: a comprehensive review. Int J Gynecol Pathol. 2022.
Hernandez OV, Martinez RN, Thompson DF. Vaginal mesenchymal neoplasms: diagnostic challenges and clinicopathological features. Am J Surg Pathol. 2019.
Santos GL, Kimura S, Wong LC. Biphasic tumors of the lower female genital tract: report of three cases. Ann Diagn Pathol. 2016.
WHO Classification of Tumours Editorial Board. Tumours of the vagina: WHO classification of tumours of the female reproductive organs. Lyon: IARC Press; 2020.
Medication Comparisons
Compare medications used to treat Benign Vaginal Mixed Epithelial And Mesenchymal Neoplasm C1511106. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy